In Russia, a registration certificate was issued for a generic drug, the patent for which belongs to Novo Nordisk until 2035
This is written by pharm.reviews, referring to the Russian media
Author name: Вікторія МАКАРЕНКО
Distributor of a drug that killed more than 65 children in Uzbekistan asks for permission to sell other drugs
The Uzbek Pharmaceutical Agency, in turn, is seeking the destruction of all drugs from India’s Marion Biotech
From 2024, transplantation will be transferred to the Medical Guarantee Program
This was discussed today during the scientific and practical conference “Development of the Transplantation System in Ukraine: Quality and Safety,” said Mykhailo Radutsky
A pilot project on dispensing medicines by QR code is being implemented in Kazakhstan
This pilot allows to ensure transparency at all stages of receiving the service by citizens
In 2024, the NHRI plans to introduce criteria for assessing the quality of rehabilitation services
Mihail Radutskyy said that the NHRI together with international partners is already working on introducing KPIs for institutions providing rehabilitation services from 2024
Nobel Prize in Medicine shared by scientists studying mRNAs
Katalin Carico and Drew Weissman of the University of Pennsylvania jointly won the 2023 Nobel Prize in Physiology or Medicine for discoveries that led to the development of mRNA vaccines against COVID-19
New scandal: the Ministry of Health of Kazakhstan was accused of non-payment of services to the French company Conseil Sante
The Ministry of Health, however, explained that they were dissatisfied with her work
On October 1, the Public Health System Act went into effect. What will change?
How the system of disease prevention will work, said the chairman of the specialized Committee of the Verkhovna Rada Mikhail Radutskyy
What drugs are planned to be banned from sale in pharmacies in Kazakhstan?
The Ministry of Health of Kazakhstan has already prepared the necessary amendments
Inspiring stories about the nation’s heroes: SCHONEN brand and 1+1 Ukraine channel launched the project “People for Life”
SCHONEN together with 1+1 Ukraine launched a large-scale social project “People for Life”, which will tell the stories of Ukrainian doctors and other professionals who save lives while remaining behind the scenes
Pharmaceutical company Gilead Sciences may pay $246 million to settle a lawsuit over the delay in the release of generic drugs
Gilead Sciences commits to pay $246.75 million to customers who have purchased Atripla or Truvada, or generic versions of these drugs over the past five years
STADA presented the results of the international study STADA Health Report 2023
STADA Health Report 2023 contains data that helps to better understand people’s behavior, pharmaceutical and health literacy, and healthcare trends.